Angeles Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Angeles Wealth Management's BMY Position: Q1 2026 in Review
Angeles Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.94% in Q1 2026, buying an estimated $11.4K and bringing the position to 20,951 shares worth $1.27M. The position accounts for 0.07% of the portfolio, ranked #108.
Angeles Wealth Management first reported a position in BMY in Q1 2022 and has held it in 17 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Angeles Wealth Management held 20,951 shares of Bristol-Myers Squibb worth $1.27M as of Q1 2026.
- Angeles Wealth Management bought 196 Bristol-Myers Squibb shares in Q1 2026, an estimated $11.4K.
- Bristol-Myers Squibb made up 0.07% of Angeles Wealth Management's portfolio in Q1 2026, its #108 holding.
- Angeles Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 17 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.